Because RBness shared the transcriptional profile of RB1-defective cancers and was associated with aggressive forms of cancer, we next asked whether these cancers shared therapeutic vulnerabilities with RB1-defective cancers that could be exploited for designing targeted therapies. Here, RB1 is linked to cancer.